CYPHNasdaqPharmaceutical PreparationsFiscal year ends December 31

CYPHERPUNK TECHNOLOGIES INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026

$2.53−0.04 (-1.56%)

Close on Oct 19, 2026

Market cap: $549.88M
P/E (TTM): 36.1
Dividend yield: –

CYPHERPUNK TECHNOLOGIES INC. balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31
Cash & Equivalents	14	47	71	66	115	52	3.89	16	26	0.79	0.41
Cash & Short-Term Investments	14	47	71	66	115	52	3.89	16	26	0.79	0.41
Prepaid Expenses & Other	0.04	0.09	0.18	0.35	0.77	0.13	0.17	0.20	0.18	0.18	–
Other Current Assets	–	–	–	–	–	–	–	–	–	0.04	–
Total Current Assets	162	48	72	68	117	52	4.24	17	28	4.03	–
Property, Plant & Equipment	–	0.01	0.01	0.02	0.04	0.07	0.12	0.09	0.14	0.12	–
Gross Property, Plant & Equipment	0.23	0.23	0.23	0.23	0.23	0.23	0.26	0.21	0.21	0.14	–
Accumulated Depreciation	-0.23	-0.22	-0.22	-0.21	-0.19	-0.16	-0.14	-0.12	-0.07	-0.03	–
Operating Lease Right-of-Use Assets	0.04	0.26	0.26	0.67	0.46	0.53	1.03	1.76	–	–	–
Deferred Tax Assets	–	–	–	–	0.16	0.18	0.13	0.12	–	–	–
Other Long-Term Assets	–	–	–	0.03	0.09	–	–	1.54	1.11	0.91	–
Total Assets	163	49	73	70	118	54	7.45	19	29	6.46	–
Accounts Payable	1.98	4.74	6.47	5.66	4.19	2.72	4.57	3.58	2.62	3.23	–
Accrued Expenses	2.07	8.54	5.96	5.15	5.37	2.75	3.44	2.87	3.46	2.66	–
Current Portion of Leases	0.04	0.27	0.26	0.42	0.43	0.41	0.47	–	–	–	–
Current Income Taxes Payable	0.47	0.53	–	–	–	–	–	–	–	–	–
Deferred Revenue (Current)	–	–	–	–	–	1.50	–	–	–	–	–
Total Current Liabilities	4.56	14	13	11	9.99	7.37	8.49	6.45	6.08	36	–
Long-Term Leases	–	–	–	0.26	0.04	0.14	0.55	–	–	–	–
Operating Lease Liabilities	0.04	0.27	0.26	0.68	0.47	0.55	1.03	1.76	–	–	–
Deferred Tax Liabilities	5.12	–	–	–	–	–	–	–	–	–	–
Total Liabilities	9.68	14	13	11	10	7.72	9.20	9.90	18	36	–
Common Stock	0.08	0.04	0.03	0.01	0.09	0.06	0.02	0.02	0.01	–	–
Additional Paid-In Capital	616	503	460	377	372	270	193	162	142	0.15	–
Retained Earnings	-463	-467	-400	-318	-264	-223	-195	-154	-130	-101	–
Comprehensive Income & Other	-0.10	-0.12	0.11	0.13	-0.27	-0.58	0.08	0.30	-0.27	0.29	–
Shareholders' Equity	154	35	60	59	108	47	-1.75	9.18	11	-100	-70
Total Equity	154	35	60	59	108	47	-1.75	9.18	11	-100	-70
Total Liabilities & Equity	163	49	73	70	118	54	7.45	19	29	6.46	–
Shares Outstanding(shares)	84	38	26	9.90	5.97	5.97	2.42	1.47	1.24	0	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2025: 5.1%

Financial strength

Current ratio: 79.19
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 438.9%

Valuation

P/E ratio: 36.1
Price to sales: –
Price to book: 3.95
Dividend yield: –